Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus: Results from the ATLAS trial

Lars Rydén, P. W. Armstrong, J. G F Cleland, J. D. Horowitz, B. M. Massie, M. Packer, P. A. Poole-Wilson